New £8.6m Campus for Future Living opens in Mablethorpe
According to ELDC, the campus is part of a vision to bring professionals and the community together to understand local health challenges.It is strongly linked to the medical school at the University of Lincoln, which opened in 2019 as well as the University of Nottingham.The council said the site would provide a permanent base for researchers, education and wellbeing teams.The campus will be operated by Acis Group, a charity supporting communities through housing, skills and education, across Lincolnshire, Yorkshire and the Humber, North Derbyshire and Nottinghamshire.
Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE I had a headache for a year... it turned out to be a deadly infection
A woman who endured a headache for nearly a year was stunned to learn that her symptoms were caused by a rare brain infection contracted from consuming raw dairy. The unnamed 25-year-old from Syria had spent a month battling the pain that would worsen when she lay down. When it became unbearable, the woman finally visited a local hospital and was diagnosed with an active frontal headache. Doctors prescribed painkillers and she was sent home. But her condition deteriorated, and she developed photophobia, blurred vision, tinnitus, nausea and vomiting. Two weeks later, she returned to the hospital - only to be told once again she was suffering from a normal headache. The condition persisted for more than 10 months as doctors continued to hunt for the underlying cause. Eventually, after a series of blood and cerebrospinal fluid tests, doctors detected antibodies of Brucella - a bacteria typically found in unpasteurized dairy - in her system. This led to a diagnosis of Brucellosis, a rare infection that can cause damage to the heart, central nervous system and liver. Although she did not display classic symptoms such as fever or joint pain, further evaluation pointed to Brucella meningitis, a serious complication of Brucellosis that occurs when the infection reaches the brain and spinal cord. Brucellosis is prevalent in the Mediterranean and Middle East, and can spread to humans from infected animals, including cows, pigs, goats, sheep and dogs, from contact with their bodily fluids or breathing the bacteria in. However, drinking unpasteurized milk or eating unpasteurized milk products such as fresh cheese can also put people at risk of developing the infection. Once inside the body, the bacteria invade the lymph nodes or tissues, multiplying slowly. If left untreated, the infection can lead to inflammation in the inner lining of the heart chambers, damage to heart valves, restricted blood flow, pain, and stiffness and swelling in the joints that can pave the way for arthritis. While there are about 500,000 cases of Brucellosis globally every year, only about 200 cases are reported in the US. Fewer than two percent of people who develop the infection die from the disease. While Brucellosis is usually treated with antibiotics, the bacteria can invade the central nervous system, causing meningitis - inflammation of the membranes surrounding the brain and spinal cord. This can cause serious damage to the brain and spinal cord, leading to infections and nerve-related complications. Initially, those afflicted can experience severe headaches, confusion, depression and behavior changes. But the infection can rapidly worsen and cause fever, fatigue, muscle and joint pain, appetite issues, discomfort, sweating, swelling of one or both testicles, and liver inflammation. Doctors find it difficult to diagnose Brucellosis since early symptoms are similar to flu and are usually able to do so only once the infection progresses. During her first visit to the hospital, tests showed her blood and cerebrospinal fluid had normal sugar and protein levels. Additionally, they found no swelling in the nerves of her brain or any abnormalities in any part of her brain. Since the test results were clear, she was misdiagnosed with idiopathic intracranial hypertension, a condition marked by elevated pressure inside the skull without a clear cause. But she continued to return to the hospital over the span of 10 months while battling a debilitating headache and other symptoms including double vision and crossed eyes. Doctors began to re-evaluate her case. They conducted a Wright test, which mixes a patient's serum with a suspension of Brucella bacteria to find antibodies. When this, along with blood and fluid tests, confirmed the presence of Brucella bacteria antibodies, doctors finalized the diagnosis. The young woman was treated with a combination of rifampicin and doxycycline, both antibiotics used for eight weeks to combat a variety of bacterial infections. Experts also noted that combinations including doxycycline and rifampin, ciprofloxacin and ceftriaxone might be the most suitable treatment for Brucellosis. This comes a year after two South Carolina families - along with five of their pets and eight veterinarians - were exposed to Brucella after caring for an infected dog and her puppies. The dog, originally taken in as a stray by a foster family before being adopted into a permanent family, was found to be harboring the bacteria. The infection led to the death of her puppies and left her infertile. Brucella canis spreads to humans through contact with contaminated canine bodily fluids. The Centers for Disease Control and Prevention (CDC) reported that the foster family had handled the dead puppies without protective equipment, prompting fears they could have been infected. Canines can become infected through mating with an infected animal or coming into contact with infected semen, vaginal or menstrual secretions. If an infected dog is pregnant, the bacteria can be transmitted to the puppies in the womb, during birth or when drinking her milk. Infection in humans occurs when material contaminated with B. canis comes into contact with people's mucous membranes, such as their eyes and mouth, or via an open cut. People can also contract B. canis from other biological material that infected dogs produce, such as urine or feces, though these latter routes are less common.
Medical News Today
an hour ago
- Medical News Today
The cost of Farxiga on Medicare
Farxiga can cost between $400 and $600 without insurance, depending on the pharmacy and whether a person buys the brand drug or the generic. Whether Medicare can pay a share of this cost depends on the person's specific (dapagliflozin) is a Food and Drug Administration (FDA)- approved medication that can help reduce blood sugar, lower the risk of hospitalization for heart failure, decrease the risk of death from cardiovascular issues, and slow the decline of kidney function in adults with type 2 diabetes, heart failure, or chronic kidney Medicare drug coverage comes through a Medicare Part D or a Medicare Advantage prescription drug (MAPD) plan. However, whether a person can get coverage for Farxiga and how much it may cost after coverage depends on their specific of Medicare termsOut-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total amount or offer coverage. Costs can include deductibles, coinsurance, copayments, and This is the amount of money someone pays each month for Medicare coverage. Deductible: This is an annual amount a person must spend out of pocket within a certain period before Medicare starts to fund their This is the percentage of treatment costs that a person must self-fund. For Medicare Part B, coinsurance is 20%.Copayment: This is a fixed dollar amount a person with insurance pays when receiving certain treatments. For Medicare, this usually applies to prescription is the cost of a 30-day supply of Farxiga?Depending on the dispensing pharmacy, a month's supply of the branded drug Farxiga can cost more than $600 without insurance. Generic dapagliflozin costs less, though still quite pricy, with the lowest cost at around $ a Medicare drug plan may cover Farxiga or its generic version depends on the plan's specific formulary, which lists the drugs each plan includes. This is because private insurers manage Medicare Part D and MAPD plans and set their coverage drug plans must typically include coverage for at least two medications from the most commonly prescribed categories. So, if the plans do not cover the drug, they might cover an alternative. If the plans cover the drug, a person's out-of-pocket cost may depend on the tier assigned to the drug within the formulary. Higher tiers typically mean higher costs. However, as of 2025, Medicare limits a person's total annual out-of-pocket drug expenses to $2,000.A person's deductible, premium, and copay with Medicare drug plans may vary by plan. In 2025, the national base beneficiary premium for Part D is $36.78, and according to the Centers for Medicare & Medicaid Services (CMS), the average monthly premium for Medicare Advantage plans is about $ Farxiga covered under Medicare Part D?Either a Medicare Part D or MAPD plan may cover Farxiga based on the drug's tier classification in the plan's formulary. The drug's tier classification depends on the plan, though the generic may be in a lower tier than the brand drug. Lower tiers indicate more Medicare coverage and lower out-of-pocket drug a Medicare drug plan might require prior authorization before coverage is provided. This could involve step therapy, in which a person must initially try a different, equally effective, but more affordable is among the 10 drugs whose prices Medicare and pharmaceutical companies renegotiated due to the Inflation Reduction Act of 2022. This lower price may take effect in 2026.»Learn more:Does Medicare cover prescriptions?How can I get Farxiga cheaper?Some ways a person can lower their costs for Farxiga include:ordering a 90-day supply of the drug to reduce pharmacy costsusing a mail-order pharmacy, which charges lesstaking advantage of the manufacturer's discount programusing the Medicine Assistance Tool and NeedyMeds for drug assistance programs and savings adviceA person cannot typically use a pharmaceutical discount program with their Medicare coverage, but in some cases, using the program may save a person more money than using their insurance.»Learn more:Farxiga (dapagliflozin) and costTakeawayFarxiga is a medication people take to help lower blood sugar and the risk of heart or kidney problems in people with type 2 diabetes, heart failure, or chronic kidney price of Farxiga ranges from $400 to $600 without insurance, varying based on the pharmacy and whether one opts for the brand-name drug or the generic version. Typically, a Medicare Part D or MAPD plan provides Medicare drug coverage. However, coverage for Farxiga and the final cost after insurance depend on the specific details of a person's Medicare plans may cover this drug, and its price with coverage may be lower once Medicare's price negotiation starts in resourcesFor more resources to help guide you through the complex world of medical insurance, visit our Medicare hub.
Medical News Today
an hour ago
- Medical News Today
How much does Breztri cost with Medicare?
Breztri can cost around $400 without insurance. Medicare drug plans may cover inhalers for COPD, including drugs like Breztri, but specific coverage and cost depend on the exact Aerosphere is a branded metered-dose inhaler prescribed for treating long-term chronic obstructive pulmonary disease (COPD) in adults. Its active components are budesonide, glycopyrrolate, and formoterol may cover inhaler therapy for COPD with a medication such as Breztri, but no national coverage requirement exists. This means a person's exact coverage depends on the drug and their specific this coverage falls under Medicare Part D or a Medicare Advantage prescription drug (MAPD) plan. However, if a person needs to use a nebulizer instead of an inhaler, coverage falls under Part of Medicare termsOut-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total amount or offer coverage. Costs can include deductibles, coinsurance, copayments, and This is the amount of money someone pays each month for Medicare coverage. Deductible: This is an annual amount a person must spend out of pocket within a certain period before Medicare starts to fund their This is the percentage of treatment costs that a person must self-fund. For Medicare Part B, coinsurance is 20%.Copayment: This is a fixed dollar amount a person with insurance pays when receiving certain treatments. For Medicare, this usually applies to prescription much is a 30-day supply of a Breztri inhaler?A 5.8-gram (g) Breztri inhaler costs around $400 without insurance, while a 10.7-g inhaler is about double this or not Medicare drug plans cover a Breztri inhaler depends on their formularies, which are lists of covered drugs that differ per plan. If the plan does not cover this drug, it may cover an alternative the plan does cover the drug, how much a person pays out of pocket after coverage depends on the drug's tier classification in the formulary. Generally, the higher the tier, the more a person of 2025, a person's total out-of-pocket annual expenses on drugs with Medicare have a $2,000 is also important to remember that private insurers administer Part D and MAPD plans. This means that their deductibles, premiums, and copays vary by 2025, the national base beneficiary premium for Part D is $36.78, and according to the Centers for Medicare & Medicaid Services (CMS), the average monthly premium for Medicare Advantage plans is around $ a person using a nebulizer covered by Part B may pay 20% of the cost after they meet their annual deductible of $257, assuming they remain covered by paying their monthly premium of $185.»Learn moreAre COPD inhalers covered by Medicare?Is there a generic drug for Breztri?A generic drug is a precise replica of the active ingredient found in a brand-name medication. Typically, generics are less expensive under Medicare than their brand-name counterparts. This is because Medicare drug plans tend to place them in lower tiers, making them more affordable. However, Breztri Aerosphere is exclusively available as a brand-name product and does not have a generic Breztri may be more costly, a person's drug plan may ask them to undergo prior authorization before approving coverage. This process may include step therapy, which is when a person tries an alternative, similarly effective, and less costly medication first.»Learn more:Breztri Aerosphere and costAre people with Medicare coverage eligible for $35 inhalers?Starting in June 2024, some pharmaceutical companies implemented a monthly spending limit of $35 for inhalers. This limit applies to people regardless of whether they have private those with government-funded health insurance, like Medicare or Medicaid, do not qualify for the $35 inhaler manufacturer of Breztri, AstraZeneca, offers a separate cost assistance program for Medicare beneficiaries who still need help paying for certain drugs. To see whether they qualify, a person can visit the manufacturer's Aerosphere is a brand-name inhaler used to manage COPD in adults in the long term. While Medicare drug plans might provide coverage for COPD inhaler treatments like Breztri, there is no universal mandate for them. This means that a person's specific coverage varies based on the medication and their particular this coverage is available for Medicare Part D or a Medicare Advantage prescription drug (MAPD) plan. However, if someone requires a nebulizer instead of an inhaler, coverage falls under Part B. The specific plan determines the exact coverage and resourcesFor more resources to help guide you through the complex world of medical insurance, visit our Medicare hub.
